DEA schedule
Is Remicade a controlled substance?
Remicade contains infliximab. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Remicade (infliximab) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and infliximab is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Remicade?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | infliximab is not on the list |
Remicade NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 57894-030 | REMICADE | injection, powder, lyophilized, for solution | 100 mg/10mL | Janssen Biotech, Inc. | None |
Questions
Is Remicade a controlled substance?
No. Remicade (infliximab) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and infliximab is not on the DEA controlled substances list.
Is Remicade a narcotic?
No. Remicade (infliximab) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Tumor Necrosis Factor Blocker.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.